Genmab focuses on products to treat various cancers, where human antibodies are expected to be particularly useful as they should lend themselves to long-term therapy without the risk of rejection by the body's immune system.
During the week Liz works as a postdoc at the Department of Pharmacology and Pathophysiology at the University of Utrecht. She spends her weekends pursuing her other passion: art. She enjoys her science career but still has some doubts about it too. Science demands 110% of one's time, which is a big commitment to make...
